Cargando…
EGFR-Targeting as a Biological Therapy: Understanding Nimotuzumab's Clinical Effects
Current clinical trials of epidermal growth factor receptor (EGFR)-targeted therapies are mostly guided by a classical approach coming from the cytotoxic paradigm. The predominant view is that the efficacy of EGFR antagonists correlates with skin rash toxicity and induction of objective clinical res...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757402/ https://www.ncbi.nlm.nih.gov/pubmed/24212794 http://dx.doi.org/10.3390/cancers3022014 |